株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国におけるオーソバイオロジクス市場の見通し

United States Orthobiologics Market Outlook to 2021

発行 GlobalData 商品コード 297036
出版日 ページ情報 英文 86 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
米国におけるオーソバイオロジクス市場の見通し United States Orthobiologics Market Outlook to 2021
出版日: 2015年09月11日 ページ情報: 英文 86 Pages
概要

当レポートでは、米国におけるオーソバイオロジクス市場について、代用骨移植片、関節内補充薬、自家骨移植片、骨成長刺激装置のカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などを提供しまとめており、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • オーソバイオロジクス市場の区分
  • 本レポートで対象としている市場の定義

第3章 米国におけるオーソバイオロジクス市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 主要企業の概要

  • Medtronic, Inc.
  • DePuy Companies
  • Sanofi
  • Globus Medical, Inc.
  • NuVasive, Inc.
  • Stryker Corporation
  • DJO Finance LLC
  • Biomet, Inc.
  • Baxter International Inc.
  • Smith & Nephew Plc
  • Anika Therapeutics, Inc.
  • Wright Medical Group, Inc.
  • 生化学工業

第5章 パイプライン製品

第6章 財務取引の情勢

  • 買収
  • 資本取引
  • 社債発行
  • 株式発行
  • 提携
  • プライベート・エクイティ
  • ベンチャー資金調達

第7章 最近の動向

  • コーポレートコミュニケーション
  • 財務発表
  • 政府および世論の関心
  • 法規制
  • その他の重要な動向
  • 製品情報
  • 戦略および事業企画

第8章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECC1025DB

GlobalData's new report, "United States Orthobiologics Market Outlook to 2021", provides key market data on the United States Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Orthobiologics market categories - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Orthobiologics market.
  • Global corporate-level profiles of key companies operating within the United States Orthobiologics market.
  • Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Orthobiologics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Orthobiologics Market, United States

  • 3.1. Orthobiologics Market, United States, Revenue ($m), 2007-2014
  • 3.2. Orthobiologics Market, United States, Revenue ($m), 2014-2021
    • 3.2.1. Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Viscosupplementation Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.4. Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.5. Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.6. Viscosupplementation Market, United States, Revenue ($m), by Segment, 2014-2021
  • 3.3. Orthobiologics Market, United States, Volume (Units), 2007-2014
  • 3.4. Orthobiologics Market, United States, Volume (Units), 2014-2021
    • 3.4.1. Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Viscosupplementation Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.4. Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.5. Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.6. Viscosupplementation Market, United States, Volume (Units), by Segment, 2014-2021
  • 3.5. Orthobiologics Market, United States, Average Price ($), 2007-2021
  • 3.6. Orthobiologics Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Orthobiologics Market, United States, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in United States, Orthobiologics Market

  • 4.1. DePuy Companies
    • 4.1.1. Company Overview
  • 4.2. Sanofi
    • 4.2.1. Company Overview
  • 4.3. Medtronic plc
    • 4.3.1. Company Overview
  • 4.4. Ferring International Center S.A.
    • 4.4.1. Company Overview
  • 4.5. Bioventus LLC
    • 4.5.1. Company Overview
  • 4.6. DJO Finance LLC
    • 4.6.1. Company Overview
  • 4.7. Stryker Corporation
    • 4.7.1. Company Overview
  • 4.8. Seikagaku Corporation
    • 4.8.1. Company Overview
  • 4.9. Arthrex, Inc.
    • 4.9.1. Company Overview
  • 4.10. Biomet, Inc. (Inactive)
    • 4.10.1. Company Overview
  • 4.11. Wright Medical Group, Inc.
    • 4.11.1. Company Overview
  • 4.12. Baxter International Inc.
    • 4.12.1. Company Overview

5. Orthobiologics Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Debt Offerings
    • 6.1.1. Medtronic Raises USD500 Million in Private Placement of Notes Due 2020
    • 6.1.2. Medtronic Raises USD2.5 Billion in Private Placement of 2.5% Notes Due 2020
    • 6.1.3. Medtronic Raises USD2.5 Billion in Private Placement of 3.15% Notes Due 2022
    • 6.1.4. Medtronic Raises USD4 Billion in Private Placement of 3.5% Notes Due 2025
    • 6.1.5. Medtronic Raises USD2.5 Billion in Private Placement of 4.375% Notes Due 2035
    • 6.1.6. Medtronic Raises USD4 Billion in Private Placement of 4.625% Notes Due 2045
    • 6.1.7. Medtronic Raises USD1 Billion in Private Placement of Notes Due 2018
  • 6.2. Equity Offerings
    • 6.2.1. Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million
    • 6.2.2. Histogenics Prices IPO for USD65 Million
  • 6.3. Merger
    • 6.3.1. Wright Medical to Merge with Tornier
    • 6.3.2. AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction
  • 6.4. Partnerships
    • 6.4.1. CollPlant to Enter into Agreement with US based company
    • 6.4.2. Osiris Therapeutics Enters into Co-Development Agreement with Arthrex for Cartiform
  • 6.5. Venture Financing
    • 6.5.1. Tissue Regeneration Raises USD0.5 Million in Venture Financing

7. Appendix

  • 7.1. Research Methodology
    • 7.1.1. Coverage
    • 7.1.2. Secondary Research
    • 7.1.3. Primary Research
    • 7.1.4. Market Modeling and Forecasting
    • 7.1.5. Company Share Analysis
    • 7.1.6. Distribution Share Analysis
  • 7.2. Expert Panel
  • 7.3. GlobalData Consulting
  • 7.4. Contact Us
  • 7.5. Disclaimer

List of Tables

  • Table 1: Orthobiologics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Orthobiologics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 6: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 7: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 9: Orthobiologics Market, United States, Volume (Units), Historic, 2007-2014
  • Table 10: Orthobiologics Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 11: Bone Grafts and Substitutes Market, United States, Volume (Units), Historic, 2007-2014
  • Table 12: Bone Growth Stimulators Market, United States, Volume (Units), Historic, 2007-2014
  • Table 13: Viscosupplementation Market, United States, Volume (Units), Historic, 2007-2014
  • Table 14: Bone Grafts and Substitutes Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 15: Bone Growth Stimulators Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 16: Viscosupplementation Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 17: Orthobiologics Market, United States, Average Price ($) Historic, 2007-2014
  • Table 18: Orthobiologics Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 19: Orthobiologics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 20: Orthobiologics Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 21: Orthobiologics Market Pipeline Products
  • Table 22: Medtronic Raises USD500 Million in Private Placement of Notes Due 2020
  • Table 23: Medtronic Raises USD2.5 Billion in Private Placement of 2.5% Notes Due 2020
  • Table 24: Medtronic Raises USD2.5 Billion in Private Placement of 3.15% Notes Due 2022
  • Table 25: Medtronic Raises USD4 Billion in Private Placement of 3.5% Notes Due 2025
  • Table 26: Medtronic Raises USD2.5 Billion in Private Placement of 4.375% Notes Due 2035
  • Table 27: Medtronic Raises USD4 Billion in Private Placement of 4.625% Notes Due 2045
  • Table 28: Medtronic Raises USD1 Billion in Private Placement of Notes Due 2018
  • Table 29: Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million
  • Table 30: Histogenics Prices IPO for USD65 Million
  • Table 31: Wright Medical to Merge with Tornier
  • Table 32: AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction
  • Table 33: CollPlant to Enter into Agreement with US based company
  • Table 34: Osiris Therapeutics Enters into Co-Development Agreement with Arthrex for Cartiform
  • Table 35: Tissue Regeneration Raises USD0.5 Million in Venture Financing
  • Table 36: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Orthobiologics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Orthobiologics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 9: Orthobiologics Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 10: Orthobiologics Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 11: Bone Grafts and Substitutes Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 12: Bone Growth Stimulators Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 13: Viscosupplementation Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 14: Bone Grafts and Substitutes Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 15: Bone Growth Stimulators Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 16: Viscosupplementation Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 17: Orthobiologics Market, United States, Company Share (%) 2014
  • Figure 18: GlobalData Epidemiology-Based Forecasting Model
  • Figure 19: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 20: Primary Interviews by Participant Type (%)
Back to Top